Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 18/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8480574 | 1.00 | TACR1 (0.51) | TACR1CA1CA2CA4CA9 | |
| Hydrochloric Acid SCHEMBL8478985 | 0.99 | TACR1 (0.50) | TACR1CA1CA2CA4CA9 | |
| Hydrochloric Acid SCHEMBL7815938 | 0.99 | TACR1 (0.50) | TACR1CA1CA2CA4CA9 | |
| SCHEMBL7829861 | 0.90 | TACR1 (0.49) | TACR1CA1CA2CA4CA9 | |
| SCHEMBL7826647 | 0.88 | TACR1 (0.51) | TACR1CA1CA2CA4CA9 | |
| Hydrochloric Acid SCHEMBL7830176 | 0.87 | TACR1 (0.51) | TACR1CA1CA2CA4CA9 | |
| SCHEMBL7650068 | 0.86 | TACR1 (0.47) | TACR1 | |
| SCHEMBL8478086 | 0.85 | IDE (0.49) | TACR1CA1CA2CA4CA9 | |
| SCHEMBL7122736 | 0.85 | IDE (0.49) | TACR1CA1CA2CA4CA9 | |
| Hydrochloric Acid SCHEMBL8475499 | 0.81 | TACR1 (0.64) | TACR1CA1CA2CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0655442-B1 | Piperazine derivatives as Tachykinin antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-05-23 | — | — | EP | disclosed |
| EP-0655442-A1 | Piperazine derivatives as Tachykinin antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-05-31 | — | — | EP | disclosed |